Tiziana Life Sciences Ltd (TLSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 64 | 5,800 |
| Other current assets | 2,384 | 390 |
| TOTAL | $2,448 | $6,190 |
| Non-Current Assets | ||
| PPE Net | 46 | 40 |
| TOTAL | $46 | $40 |
| Total Assets | $2,471 | $6,230 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 4,740 | 2,140 |
| TOTAL | $4,749 | $2,140 |
| Non-Current Liabilities | ||
| TOTAL | $N/A | $N/A |
| Total Liabilities | $4,749 | $2,140 |
| Shareholders' Equity | ||
| Common Shares | 8,140 | 6,900 |
| Retained earnings | -42,613 | -29,720 |
| Other shareholders' equity | 915 | 17,960 |
| TOTAL | $-2,278 | $4,080 |
| Total Liabilities And Equity | $2,471 | $6,220 |